{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-032355","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.421602+00:00","generated_at":"2026-05-25T14:28:03.565358+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MyoKardia terminates Fulcrum collaboration; Fulcrum loses future milestones and royalties","bullets":["MyoKardia (BMS unit) terminated the collaboration agreement for convenience; effective June 26, 2025.","Fulcrum forfeits all future milestone payments (up to $298.5M per target), royalties, and research cost reimbursement.","Fulcrum had received $10M upfront, $2.5M prepaid research funding, and achieved a $2.5M preclinical milestone.","Parties will continue obligations until June 26, 2025; no further revenues from the agreement after termination."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-032355","json":"https://secwatch.observer/filing/0000950170-25-032355.json","markdown":"https://secwatch.observer/filing/0000950170-25-032355.md","text":"https://secwatch.observer/filing/0000950170-25-032355.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000095017025032355/0000950170-25-032355-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000095017025032355/fulc-20250226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T14:28:03.565358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}